Chief Executive Officer
Wed, Dec 21, 2022
Dec 21
12,500 shares @ $20.32
Decreased holdings by -1.00%
3rd largest trade (out of 185)
Trade made by an officer
55% win rate · -2.5% median edge vs SPY (11 trades, 90-day · small sample)
Price 23% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology